AstraZeneca's revenue from top product Crestor 2006-2023

Published by
Matej Mikulic,
Feb 28, 2024
This statistic describes AstraZeneca's revenue from one of its top products, Crestor, from 2006 to 2023. In 2023, the revenue amounted to 1.1 billion U.S. dollars. AstraZeneca plc is one of the top 10 pharmaceutical companies worldwide (based on Rx drug revenue). The multinational company is headquartered in London, UK. AstraZeneca is focused on products for following major disease areas: cancer, cardiovascular, gastrointestinal, infection, neuroscience, respiratory and inflammation.

AstraZeneca's revenue fom top product Crestor from 2006 to 2023 (in million U.S. dollars)

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Source

Use Ask Statista Research Service

Release date

February 2024

Region

Worldwide

Survey time period

2006 to 2023

Supplementary notes

Figures prior to 2021 were taken from previous annual reports.

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Pharmaceutical products: Crestor (rosuvastatin) and Nexium (esomeprazole) "

The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Pharmaceutical products: Crestor (rosuvastatin) and Nexium (esomeprazole)

Overview

8

Consumer behavior and drug prices

5

Advertising expenditures

3

Further related statistics

20

Further Content: You might find this interesting as well

Statistics

Topics

Pharmaceutical market in ThailandDemographics of ThailandHealth in ThailandMedical device industry in ThailandCoronavirus (COVID-19) pandemic in Thailand
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.